Atlas Trials

Two Part Study of Nenocorilant Combined With Nivolumab in Patients With Advanced Solid Malignancies

Clinical trial NCT07276373 · RECRUITING

Trial details

NCT number
NCT07276373
Sponsor
Corcept Therapeutics
Status
RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Neoplasms
Start date
2026-01-16
Primary completion
2026-09-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.